Inquiry proceedings at a Dutch chipmaker
Updated on .
Nexperia is a Dutch chipmaker with a Chinese shareholder. A conflict over the CEO's management led to intervention by the Enterprise Chamber (Ondernemingskamer). It suspended the director and temporarily placed control over almost all the shares with an administrator. The dispute developed into proceedings in the Netherlands and China over management, control, loans and damages. On 11 November 2026, the Enterprise Chamber imposed further measures against the Chinese shareholders and a Chinese subsidiary, including measures against the use of Chinese proceedings to undermine the inquiry.
Nexperia, Wingtech and Yuching: who is who?
The Nexperia group is based in Nijmegen and was formerly part of Philips and later NXP. It makes chips for cars and consumer electronics, among other uses, with factories in several countries. The Dutch companies Nexperia Holding B.V. and Nexperia B.V. are central to the inquiry proceedings. The Chinese group company Nexperia (China) Ltd. is referred to below as Nexperia China. References below to Nexperia alone mean the group; where a dispute concerns a particular company, that company is identified separately.
The group has been owned by China's Wingtech Technology since 2019. Wingtech holds its interest through Yuching Holding Limited in Hong Kong. Yuching is the direct shareholder of Nexperia Holding; Wingtech is the indirect shareholder. This distinction matters: the Dutch court measures concern the Dutch companies and the shares held by Yuching in Nexperia Holding. (Gelderland District Court 2 September 2026, paras 3.2-3.3.)
The chief executive officer (CEO) held several roles. He was an executive director of Nexperia B.V., non-executive chair of Nexperia Holding and a director of Yuching. He also held an indirect interest of about 15% in Nexperia and a controlling interest in WSS, a Chinese supplier of wafers. Wafers are semiconductor discs from which chips are made. His different interests intersected when Nexperia bought from WSS. (Enterprise Chamber 13 October 2025, paras 2.3-2.5 and 3.18.)
A conflict arose within Nexperia over the CEO's decision-making and the position of other senior officers. The chief legal officer (CLO) was also a director formally appointed to the boards of both Dutch companies. Acting for those companies, he asked the court to intervene. The companies were therefore seeking an investigation into the conduct of their own management. (Enterprise Chamber 13 October 2025, paras 2.3 and 3.8.)
What inquiry proceedings before the Enterprise Chamber involve
The Enterprise Chamber is a specialist chamber of the Amsterdam Court of Appeal. In inquiry proceedings, it can order an investigation into a legal entity's policy and conduct of affairs. There must be well-founded reasons to doubt their propriety; the Enterprise Chamber also weighs the interests involved. Whether there has been mismanagement may be determined after the investigation. (Enterprise Chamber 11 February 2026, para. 3.33.)
The Enterprise Chamber may also impose temporary measures to stabilise relationships within the company. Examples include suspending a director, appointing an independent director and transferring shares to an administrator for management purposes. Under the last of these measures, an administrator temporarily exercises the control attached to the shares under administration. These temporary measures can therefore apply while the investigation is still in progress.
At Nexperia, three questions must be distinguished: which management decisions raised doubts, which measures were necessary to protect the business, and what structural solution may ultimately be possible? The first two questions explain the intervention from October 2025. The third is central to the later debate about a possible break-up.
Export rules and government intervention increased the pressure
The international ownership structure brought US export restrictions into play. Wingtech was placed on the US Entity List with effect from 2 December 2024. This trade list subjects exports to licensing requirements. The situation became acute when the US 50% rule was published on 30 September 2025: companies at least half-owned by certain entities on that list would also face export restrictions. Wingtech indirectly held all the shares in Nexperia. On the account given in the inquiry proceedings, those restrictions threatened to apply to Nexperia sixty days later. (Bureau of Industry and Security (BIS) rule listing Wingtech, DATES and section II.A; Enterprise Chamber 13 October 2025, para. 2.28.)
On the same day, 30 September 2025, the Dutch Minister of Economic Affairs issued an order under the Goods Availability Act 1952. Its purpose was to prevent knowledge and production assets from being transferred abroad. The Investments, Mergers and Acquisitions Security Screening Act offered no route for this earlier acquisition: it predated 8 September 2020, the limit of that Act's retrospective reach. The government order and the inquiry proceedings must be distinguished in law. The Enterprise Chamber examined the governance relationships within the companies.
The government measures subsequently followed their own course. On 21 October 2025, Nexperia was exempted from the US 50% rule, according to the facts established in the inquiry proceedings. The general rule was then suspended for a year. A BIS rule published on 9 November 2026 extended that suspension up to and including 10 January 2027. According to the Enterprise Chamber, a further extension cannot be counted on. (Enterprise Chamber 11 February 2026, paras 2.72-2.73; Enterprise Chamber 11 November 2026, paras 2.50 and 4.10.)
The Minister suspended his order on 19 November 2025, initially for six months or until any earlier conclusion of the inquiry proceedings without a final decision. On 28 September 2026, he extended the order once more and at the same time largely suspended it until 20 September 2027. He noted that no long-term solution had yet been reached. At the same time, he wished to allow room for further diplomatic consultation; partly because of the Enterprise Chamber's measures, he considered that the order could remain suspended. The Enterprise Chamber did not rule on the lawfulness of that order. (Enterprise Chamber 11 February 2026, paras 2.74 and 3.34; Enterprise Chamber 11 November 2026, para. 2.42.)
The Enterprise Chamber questioned specific management decisions
The Enterprise Chamber questioned the care exercised in transactions with the supplier WSS. In its order of 11 February 2026, it distinguished the financing arrangements from subsequent orders. Nexperia had to pay a substantial proportion of its orders in advance; in 2025, that proportion was 70%. Making advance-payment arrangements did not, in itself, provide well-founded reasons to doubt the propriety of the policy. The interests of Nexperia and WSS could coincide in that respect. For each subsequent order, however, a fresh assessment was required of whether the conflict of interest had been handled with due care. (Enterprise Chamber 11 February 2026, paras 3.10-3.12.)
It was those specific orders that raised questions. Internal information put the business requirement at about USD 70-80 million, yet the director pressed for orders worth USD 200 million. Internal messages referred to wafers that might end up as scrap. The Enterprise Chamber found insufficient safeguards for the heightened care required in that relationship. A conflict of interest therefore does not make every transaction unacceptable; the decision-making on individual transactions must withstand scrutiny. Section 2:239(6) of the Dutch Civil Code (DCC) requires a director with a conflicting personal interest to take no part in the relevant deliberations or decision-making. The transaction must also be prepared and carried out with due care. (Enterprise Chamber 13 October 2025, paras 3.17-3.18; Enterprise Chamber 11 February 2026, paras 3.12-3.15.)
A second issue concerned the undertakings given to the Ministry of Economic Affairs. Nexperia had approached the Ministry itself because of perceptions surrounding its Chinese ownership. Its undertakings included a supervisory board with special approval rights and a security structure. The discussions were voluntary. Withdrawing those undertakings was therefore insufficient, in itself, to cast doubt on the propriety of the policy. The allegation concerned the way Nexperia informed the Ministry and third parties of its change of direction.
The Minister sent a letter of support in August 2024. Nexperia used that letter in dealings with third parties, while the director retreated from the previously proposed governance structure between late August and late September. The assumptions underlying the letter of support, which had become outdated, were not promptly corrected. In the Enterprise Chamber's view, the Ministry had thereby been strung along. This conduct was taken into account in assessing the care exercised in decision-making. (Enterprise Chamber 11 February 2026, paras 3.17-3.19.)
Financial management was also disrupted. On the CEO's instructions, the banking powers of attorney held by the chief financial officer (CFO) and two finance officers were revoked on 4 September 2025. No business justification was given. Those powers passed to people without particular financial experience. The CLO and several other key officers were then given notice of dismissal. The works council had not been informed, while the proposed dismissal of the CLO from the board also engaged its right to advise under Section 30 of the Works Councils Act. (Enterprise Chamber 13 October 2025, paras 2.22 and 3.21.)
The Enterprise Chamber suspended the CEO and placed shares under administration
On 1 October 2025, Nexperia Holding and Nexperia B.V. petitioned the Enterprise Chamber for an investigation and immediate measures. Measures were imposed that same day without hearing the opposing parties first. The CEO was suspended, all the shares in the holding company were transferred for management purposes to an administrator yet to be appointed, and a provision of the board regulations governing the CEO's powers was suspended. The Enterprise Chamber initially kept the proceedings confidential. It justified this exceptional approach by reference to the urgency and the risk of irreversible consequences for the business. (Enterprise Chamber 1 October 2025, operative part; Enterprise Chamber 13 October 2025, paras 3.11-3.15.)
A hearing involving the interested parties followed on 6 October. The next day, the measures remained in place, with an important adjustment: all but one of the shares would now be administered. The remaining share stayed outside the administration, preserving Yuching's access to the general meeting and the information provided there. An independent non-executive director was also appointed, with a casting vote and independent authority to represent the companies. Administration of the shares temporarily shifted the exercise of control to the administrator. (Enterprise Chamber 7 October 2025, para. 3.6 and operative part.) The shareholder retained the economic rights and the power to sell the shares under administration; the rights to attend meetings and vote on those shares temporarily passed to the administrator. (Enterprise Chamber 11 February 2026, para. 3.40.)
The non-disclosure order was lifted in stages. On 8 October, an exception was made for diplomatic discussions. The order was lifted in full on 13 October, after Wingtech had made the case public in China. The Dutch State had requested that the order be lifted in full, and Nexperia supported that request. In the Enterprise Chamber's view, continued secrecy no longer served a reasonable purpose. (Enterprise Chamber 8 October 2025, operative part; Enterprise Chamber 13 October 2025, paras 1.3-1.6 and 2.1.)
Why Nexperia could petition for an inquiry itself
The petition came from the companies themselves. Section 2:346(1)(e) DCC permits this. Under the articles of association, the CLO had only joint authority to represent the companies. Even so, he could submit the petition independently because it concerned the conduct of his fellow director. The Enterprise Chamber accepted an exception to the ordinary rules on representation, in line with the Johema order. (Enterprise Chamber 13 October 2025, para. 3.8.)
Yuching and the suspended director argued that the Dutch court lacked a sufficient basis for jurisdiction. They pointed to their respective registered office and residence in Hong Kong and to the possible consequences for recognition of Dutch decisions abroad. The Enterprise Chamber responded that the investigation concerned two Dutch companies which were themselves seeking that investigation. The case also had a sufficient connection with the Dutch legal order in relation to the foreign parties involved. The principal basis was Section 3(c) of the Dutch Code of Civil Procedure (DCCP); the Enterprise Chamber also referred to Section 6(h) DCCP. (Enterprise Chamber 13 October 2025, paras 3.1-3.4.)
In the Enterprise Chamber's view, the investment protection treaty between the Netherlands and China likewise did not preclude its jurisdiction or the measures sought. The suspension of directors and temporary administration of shares are also applied to Dutch directors and shareholders. The measures were therefore not considered discriminatory. This ruling concerns jurisdiction and measures in these inquiry proceedings; the subsequent Chinese proceedings involve their own claims and legal tests. (Enterprise Chamber 13 October 2025, para. 3.5.)
The investigation covers four subjects
On 11 February 2026, the Enterprise Chamber then ordered the investigation into the policy and conduct of affairs from 1 December 2023 up to and including the date of that order. Four subjects are central: the conflict of interest; decision-making under pressure from US trade restrictions and contact with the government; the banking powers of attorney and notices of dismissal; and the division within the group after 1 October 2025. The conduct of other board and management members may also be examined. The immediate measures remained in force. (Enterprise Chamber 11 February 2026, para. 3.35 and operative part.)
The Enterprise Chamber expressly left the causes of the disruption to the production chain open. At this stage, it did not have to establish who had caused the disruption. The fact that the group could no longer maintain its production processes because of the internal conflict itself provided a reason to doubt the propriety of the policy. The subsequent investigation must examine the events and responsibilities in greater depth. (Enterprise Chamber 11 February 2026, paras 3.30 and 3.35.)
The investigators were appointed on 17 February 2026; the investigation budget was set on 28 April. The investigation timetable later reproduced by the Gelderland court shows that 28 people were to be interviewed and that completion of the report was envisaged by December 2026 at the latest. That timetable was provisional. As at 16 November 2026, no public investigation report or newly confirmed timetable is known. (Enterprise Chamber 17 February 2026, operative part; Gelderland District Court 2 September 2026, para. 3.27.)
Appeals in cassation concern the urgent measures and the investigation
Yuching and the suspended director challenged the five urgent orders made in October 2025 by appeals in cassation to the Supreme Court. Their complaints concern, among other matters, the right to be heard, the State's admission as an interested party, the well-founded reasons for doubt, the measures imposed and the non-disclosure order. On 12 June 2026, Advocate General Assink concluded in both cases that the complaints should not lead to the orders being set aside. (Opinion in Yuching's case; opinion in the director's case.)
His advice nevertheless requires careful reading. The opinion recommends dismissal and, for the decisions lifting the non-disclosure order, also inadmissibility. For decisions lifting such an order under Section 28 DCCP, the Advocate General proceeds on the view that no ordinary appeal is available. Section 28 DCCP does not expressly determine that question. Insofar as the order of 8 October 2025 also concerns the appointment of the share administrator, the Advocate General considers Yuching's appeal admissible. Decisions within a single order therefore do not necessarily follow the same appeal route. (Opinion of the Advocate General 12 June 2026, Yuching, sections 4.4-4.6 and 4.12.)
The State's position is also addressed. Admission as an interested party depends on whether the outcome may affect a person's own interests, or whether that person is otherwise so closely involved in the subject matter as to have an interest in taking part. This is known as the Scheipar standard. According to the Advocate General, the State's discussions about Nexperia's governance had brought it sufficiently close to the subject matter to participate as an interested party. Since Yuching's cassation complaint did not identify where it had previously challenged the State's admission, he considers the implicit application of the test sufficient. (Advocate General's opinion of 12 June 2026, Yuching, points 4.58-4.61.) His opinion is independent advice to the Supreme Court. As at 16 November 2026, no judgment in these two cases has been published.
Separate appeals in cassation followed in May 2026 against the orders of 11 and 17 February 2026 directing the inquiry and appointing the investigators. Yuching lodged its appeal on 8 May 2026. According to the Enterprise Chamber, judgment in that case is expected on 18 December 2026. As at 16 November 2026, no opinion in this second round of appeals has been published on rechtspraak.nl. The appeals against the initial emergency measures must therefore be distinguished from those concerning the investigation. Advice on the October orders does not also determine the second round of appeals in cassation. (Opinion of the Advocate General 12 June 2026, director, section 3.24; Enterprise Chamber 11 November 2026, para. 2.20.)
Dutch and Chinese damages claims pursue distinct objectives
Wingtech and Yuching seek damages and restoration of control in China. According to the Enterprise Chamber, they brought their proceedings on 7 May 2026 against Nexperia, ITEC B.V. and three Nexperia officers; the case is now pending in Dongguan. They rely on China's Anti-Foreign Sanctions Law. Among other things, they claim that Nexperia should withdraw the inquiry proceedings and that the defendants should bring the ministerial order to an end. Failing that, the claim requires Nexperia Holding, Nexperia B.V. and ITEC B.V. to transfer their shares in their subsidiaries to Wingtech unconditionally. The loss is provisionally put at CNY 8 billion, more than €1 billion. That is the Chinese claimants' demand, rather than an established loss. (Gelderland District Court 2 September 2026, para. 3.29; Enterprise Chamber 11 November 2026, para. 2.19.)
According to Wingtech's stock exchange announcement of 1 September 2026, interests held by Nexperia B.V. and ITEC B.V. in five Chinese subsidiaries had been frozen in August, up to CNY 2.14 billion and provisionally until August 2029. Wingtech received an order and notification concerning those measures on 28 August; the freezes had taken effect earlier that month. According to the Enterprise Chamber, the Dongguan court imposed this protective measure on 13 August 2026, and Wingtech provided security for it. Nexperia B.V. and ITEC B.V. objected; at the time of the Enterprise Chamber's order, no decision had been taken on that objection. No Chinese decision has been consulted here. Further prohibitions followed within that Chinese dispute on 2 November; they are discussed below. (Enterprise Chamber 11 November 2026, para. 2.29.)
On the Dutch side, according to the Enterprise Chamber, Nexperia Holding B.V. and Nexperia B.V. brought proceedings in the Amsterdam District Court on 8 October 2026 against the suspended director, Wingtech, Nexperia China and Nexperia (Shanghai) Ltd. Nexperia seeks a declaratory judgment that these parties acted unlawfully, including by taking control of the Chinese part of the group and undermining the Enterprise Chamber's measures. Nexperia also alleges that they failed to perform certain intra-group agreements. It puts its loss at USD 2 billion, or alternatively seeks damages to be assessed in separate damages proceedings. (Enterprise Chamber 11 November 2026, para. 2.46.) It confirmed the proceedings in a statement of 5 November 2026. Wingtech disputes the allegations, the causal link and the amount. In its announcement a day earlier, it also stated that the writ of summons had not yet been formally served.
These damages proceedings require findings on specific conduct, liability, causation and loss. The Enterprise Chamber's earlier doubts about the policy do not automatically answer those questions. Nor do the amounts quoted by the parties establish what a court will ultimately award. The distinction between the interests of the group, those of the shareholder and those of individual group companies remains decisive.
Yuching seeks witness evidence over a loan repayment demand
A separate dispute concerns a loan that Nexperia B.V. made in 2019 to Yuching, its indirect shareholder: the Yuching Loan. (Enterprise Chamber 11 November 2026, para. 2.14.) Nexperia B.V. demanded repayment, and Yuching disputed that demand. With a view to possible Dutch proceedings on the merits, Yuching sought to examine two Nexperia directors under oath. Gelderland District Court permitted this on 2 September 2026 only in relation to repayment of the loan and any loss caused by the demand for repayment.
According to the district court, fifteen banks terminated a USD 800 million credit facility in late 2025. They regarded the transfer of shares for management purposes as a change of control. Nexperia B.V. then terminated the loan to Yuching financed from that facility. The loan had originally amounted to USD 480 million and had since grown to more than USD 525 million. Yuching disputes the termination and alleges that Nexperia itself prompted the banks to terminate. It wished to investigate the circumstances with a view to possible Dutch proceedings on the merits. (Gelderland District Court 2 September 2026, paras 3.19-3.20 and 5.12-5.13.)
A preliminary evidentiary measure under Section 196 DCCP may be sought for such an investigation. The district court rejected the argument that the Enterprise Chamber investigation made the examination unnecessary. An investigation report is directed at assessing the policy and cannot automatically replace evidence for an individual claim. It is also uncertain whether it will contain statements made under oath. (Gelderland District Court 2 September 2026, paras 5.14-5.17.)
For the other subjects, the district court found insufficient legal interest. Yuching had also brought Chinese proceedings concerning the same facts. The interpretation of the law of evidence in force since 2025 was relevant here: according to this court, a preliminary evidentiary measure before a Dutch court cannot serve exclusively foreign proceedings. A foreign case does not exclude an examination for possible Dutch proceedings on the merits, but the remaining Dutch legal interest must then be explained. It was precisely that explanation which was missing for the subjects refused. (Gelderland District Court 2 September 2026, paras 5.23-5.28.)
The concurrent inquiry did affect timing. The directors whom Yuching wished to examine also had to cooperate with the Enterprise Chamber investigation. The examination may therefore begin only after the investigation report has been filed with the court registry in accordance with Section 2:353 DCC. The examination remains confined to the demand for repayment of the loan and any resulting loss. Within that subject, Yuching may also ask relevant questions beyond those in its original schedule. The court allows, in principle, no more than sixty minutes per witness. The need for separate evidence and protection of the ongoing investigation coexist here. (Gelderland District Court 2 September 2026, paras 5.40-5.47 and 5.51, and operative part.)
The Hague counter-order protects access to the courts
In separate intellectual property proceedings, Nexperia B.V. and Nexperia China are opposing parties. This dispute led to Dutch preliminary relief proceedings (kort geding), a procedure for obtaining a provisional court measure. The Jiangsu High People’s Court had issued an order restricting Nexperia's ability to allege infringement of its intellectual property rights against Nexperia China and related parties. Nexperia China then asked the Chinese court to use that order to block the preliminary relief proceedings in The Hague as well. The provisional relief judge therefore classified the Chinese order as an anti-suit injunction: a measure preventing a party from litigating elsewhere. (The Hague District Court 2 November 2026, corrected 5 November, paras 5.20-5.23.)
In China itself, the order stood. The court in Jiangsu dismissed Nexperia B.V.'s appeal on 29 September 2026. On the same day, it fined Nexperia B.V. CNY 58 million, equivalent to €7.8 million, for non-compliance between 4 May and 30 June 2026. (Enterprise Chamber 11 November 2026, para. 2.43.)
For jurisdiction, the place where the harm occurred was central. According to the provisional relief judge, the interference with access to the Dutch courts occurred in the Netherlands. Section 6(e) DCCP therefore provided a basis for jurisdiction. For the scope of the countermeasure, the unitary character of the EU trade mark was relevant: Nexperia could not be required to seek protection against the Chinese litigation order in every Member State separately. (The Hague District Court 2 November 2026, corrected 5 November, paras 5.9-5.13.)
In the provisional relief judge's preliminary view, the restriction on access to the courts was unlawful. Such a restriction requires, among other things, a legal basis, a legitimate aim and proportionality. In the judge's view, the Chinese order did not satisfy those requirements. Nexperia China may therefore not rely on that order within the EU. A penalty payment of €1 million per day applies, up to a maximum of €100 million. This Dutch counter-order is known as an anti-anti-suit injunction. (The Hague District Court 2 November 2026, corrected 5 November, paras 5.24-5.29 and operative part, para. 6.1.)
The relief granted has clear limits. It applies within the EU and does not set aside the Chinese decision. The separate applications for trade mark infringement injunctions were refused for lack of urgency. The judge further observed, though this was unnecessary to the decision, that the wider group conflict militated against such a far-reaching injunction in preliminary relief proceedings. The judgment therefore does not establish that the Chinese products infringe. It protects the opportunity to put that question before the competent court. (The Hague District Court 2 November 2026, corrected 5 November, paras 5.30-5.34.)
Two Circles: a proposal for future control
According to a Wingtech stock exchange announcement of 4 November 2026, the share administrator and temporary non-executive director appointed by the Enterprise Chamber have proposed a structure known as Two Circles. Wingtech would retain ownership and control of the Chinese operations. External investors would gain control of the remaining global operations, in which Wingtech would hold a minority interest. The announcement does not set out the legal structure or terms of any transaction.
Wingtech has objected in writing to a solution that the appointees would implement without its consent. It maintains that this would harm its investment interests, but says that it wishes to continue negotiations. (Wingtech, announcement of 4 November 2026, pp. 3 and 5-6.) On 21 September 2026, the appointees had informed Wingtech that they would conduct a market sounding; Wingtech rejected this on 26 September. According to the director appointed by the Enterprise Chamber, the appointees have provisionally concluded that Nexperia's interests require the shareholder structure to be revised in the short term, in the worst case involuntarily. The share administrator stresses that no decision has yet been taken on whether to pursue any particular transaction. (Enterprise Chamber 11 November 2026, paras 2.41 and 3.3-3.4.)
In a statement of 12 November 2026, the appointees gave their own account. They stated that they were not then preparing a sale of a majority stake to outside investors or a division into Chinese and non-Chinese businesses. They are exploring interest in a majority or minority stake; no decision had been taken to reduce Wingtech's interest. The Enterprise Chamber permitted the market sounding, with scope for judicial review of a solution without Wingtech's support. This does not amount to approval of a transaction.
The Chinese proceedings also complicate any implementation. At the request of Wingtech and Yuching, the court in Dongguan on 2 November 2026 prohibited Nexperia, ITEC B.V. and three Nexperia officers from, among other things, disposing of or encumbering interests in Nexperia, intellectual property and assets. Breach is subject to a fine of CNY 100,000 per day. The Chinese order itself has not been consulted here; this account follows the Enterprise Chamber. (Enterprise Chamber 11 November 2026, paras 2.37 and 2.48.)
The Enterprise Chamber prohibits Wingtech from undermining the inquiry
On 9 October 2026, Nexperia and the director appointed by the Enterprise Chamber petitioned for further measures. These were to be directed at Wingtech, Yuching, Nexperia China and five directors and senior executives of Yuching and Wingtech, including the suspended CEO. The Enterprise Chamber dealt with the petition confidentially: the hearing on 30 October was held behind closed doors and the parties were placed under a non-disclosure order, which was later partly lifted. On 11 November 2026, the Enterprise Chamber largely granted the petitions. (Enterprise Chamber 11 November 2026, paras 1.3-1.12 and 4.12.)
The inquiry regime itself does not apply to Wingtech and Yuching, as they are not Dutch legal entities. On that point, the Enterprise Chamber agreed with Wingtech. They are nevertheless bound. Yuching chose to hold shares in a company governed by Dutch law. As a shareholder, it must therefore act in accordance with the requirements of reasonableness and fairness under Section 2:8 DCC. According to the Enterprise Chamber, the same applies to Wingtech, as an indirect shareholder that is organisationally connected with Nexperia Holding and takes an active stance towards Nexperia. In this respect, it referred to the Supreme Court's Funda judgment. For the five directors, the obligation follows from their positions at Yuching, Wingtech or Nexperia. (Enterprise Chamber 11 November 2026, paras 4.3 and 4.11.)
A party that disagrees with a measure ordered by the Enterprise Chamber may lodge an appeal in cassation or, within the limits of the proper conduct of the proceedings, ask the Enterprise Chamber to amend or withdraw it. In all other respects, everyone within the scope of Section 2:8 DCC must comply with the measures and must not frustrate them. The Enterprise Chamber derived this from the purpose of the inquiry regime, which includes restoring sound relationships. In its view, the same idea underlies Section 2:357(3) DCC: the legal entity cannot undo a measure ordered by the Enterprise Chamber. (Enterprise Chamber 11 November 2026, para. 4.4.)
In the Enterprise Chamber's view, Wingtech has undermined the measures. Since October 2025, Wingtech has consolidated only Chinese Nexperia subsidiaries in its accounts and reports that the Chinese operations have become independently run. It was not disputed that Nexperia China has supplied no finished products to Nexperia since the end of September 2025 and competes directly with Nexperia, or that the Chinese subsidiaries use Nexperia's intellectual property outside the scope of the licences granted. Wingtech threatened a new partner, the Indian company Tata Electronics, with liability, relying on the assertion, factually incorrect according to the Enterprise Chamber, that Nexperia B.V.'s intellectual property belongs to Wingtech. According to the Enterprise Chamber, Wingtech has thereby removed the Chinese subsidiaries from Nexperia's control and, together with those subsidiaries, harmed Nexperia's business in an impermissible way. (Enterprise Chamber 11 November 2026, paras 2.49 and 4.5-4.8.)
A significant part of the order concerns the Dongguan proceedings. Two claims in those proceedings are aimed at the inquiry: withdrawal of the inquiry, and transfer of the shares without compensation if the inquiry and the ministerial order are not both withdrawn. According to the Enterprise Chamber, merely bringing those claims conflicts with the right of access to the courts and conflicts so seriously with Section 2:8 DCC that it is an abuse of rights, and therefore unlawful. By Dutch standards, the claim to bring the ministerial order to an end is not in itself an abuse of rights. The other claims, such as the claim for damages, do not reach that high threshold either; the Chinese court will rule on them. (Enterprise Chamber 11 November 2026, para. 4.6.)
The same assessment applied to Wingtech's application for the Chinese prohibitions of 2 November. In that application, Wingtech had also asked for the defendants to be prohibited from seeking buyers for shares in Nexperia. According to the Enterprise Chamber, the prohibition granted on transferring assets even goes so far as to make any sale of its products impossible. Wingtech had not explained that Chinese law required it to make these applications. Merely applying for these measures was an abuse of rights, and enforcing them would be equally so. (Enterprise Chamber 11 November 2026, paras 4.7 and 4.15.)
The Enterprise Chamber therefore ordered Wingtech and Yuching to withdraw the two claims concerned by 18 November 2026 and keep them withdrawn. In its view, ordering withdrawal of the entire Dongguan proceedings would go too far. Because those claims in essence amount to an anti-suit injunction, the Enterprise Chamber classified its own order as an anti-anti-suit injunction, the same device as in the Hague judgment. Wingtech's reliance on comity of courts, the principle of restraint towards foreign courts, failed. The orders are directed at Wingtech and Yuching as litigants, not at the Chinese decisions themselves. Moreover, comity as such does not form part of Dutch law. (Enterprise Chamber 11 November 2026, paras 4.14 and 4.16.)
Approaching investors is permitted, with safeguards for Wingtech
The order also makes room for a structural solution. According to the Enterprise Chamber, the appointees had convincingly explained why they now wish to talk to external investors. From contacts with customers, suppliers and governments, and from reports by McKinsey and Akin Gump among others, they could reasonably infer that the current ownership structure may, in the short term, become a serious threat to Nexperia's continuity. Particularly since they do not rule out in advance that Wingtech retains a majority interest, opposing the mere exploration of transaction scenarios is contrary to Section 2:8 DCC. (Enterprise Chamber 11 November 2026, para. 4.7.)
There are safeguards in return. The appointees must seek a solution that Wingtech supports as far as possible. They must keep Wingtech informed in outline and inform it more fully as a solution takes more concrete shape. If a solution does not have Wingtech's support, they must ensure that a Dutch court can review it, having regard also to the right to property under Article 1 of the First Protocol to the ECHR. To that end, they may themselves ask the Enterprise Chamber for a measure, or inform Wingtech of the transaction and give it time to seek an injunction itself. (Enterprise Chamber 11 November 2026, para. 4.13.)
Specific orders are backed by penalty payments
The general orders, including the order to tolerate the appointees' performance of their duties, apply without penalty payments to all eight parties concerned. In addition, five specific orders and prohibitions apply to Wingtech and Yuching. Only Wingtech and Yuching must withdraw the two Chinese claims and refrain from enforcing the Dongguan prohibitions insofar as these concern intellectual property, assets or the market sounding. The other three also apply to Nexperia China. They must tolerate the market sounding and, without the appointees' written consent, may not hold discussions with prospective investors or provide them with information. They may not obstruct Nexperia in cooperation with, among others, Tata Electronics and Polar Semiconductor, in expanding production capacity, in granting IP licences, in obtaining financing or in disposing of assets in the ordinary course of business. In proceedings against the Nexperia companies, officers or court appointees named in the operative part, they must include this order and the order of 11 February 2026 with their first subsequent written submission, with the required translations and an explanation that the Enterprise Chamber has ordered their production. (Enterprise Chamber 11 November 2026, operative part.)
Those specific orders and prohibitions carry penalty payments of €1 million or €5 million per breach or per day, up to a combined maximum of €300 million. The Enterprise Chamber acknowledged that these amounts are high and justified them by the interests at stake, the financial strength of the parties and Wingtech's conduct so far. For the five directors, it refrained for now from imposing penalty payments, because their conduct can in principle be attributed to the legal entities. The order was declared provisionally enforceable. (Enterprise Chamber 11 November 2026, paras 4.12 and 4.19, operative part.)
Wingtech does not accept the order. In a stock exchange announcement dated 16 November 2026, it announced that it would challenge the order before the Dutch courts within the statutory period. It regards the order as, in essence, a cross-border anti-suit injunction that, in its view, has no legal effect in China under Chinese law. An appeal in cassation to the Supreme Court lies against an order of the Enterprise Chamber. The Enterprise Chamber itself mentioned that option, as well as the freedom to criticise its decisions. According to the Enterprise Chamber, that freedom does not extend to questioning or undermining the appointees' authority. (Enterprise Chamber 11 November 2026, para. 4.10.)
What does this mean for directors and shareholders?
For directors, the case shows the importance of decision-making that can withstand scrutiny when personal and group interests intersect. An agreement approved earlier does not remove the need for due care when placing subsequent orders. Information given to fellow directors, the works council and external parties must also reflect the decisions actually being taken. Events at Nexperia show how quickly defective decision-making can affect financing, production and control.
For shareholders, the practical task is to substantiate their objections to a specific solution. They need information about the proposed transaction and sufficient time to seek judicial review if necessary. Information provision and timing therefore deserve attention from the market-sounding stage onwards. (Enterprise Chamber 11 November 2026, para. 4.13.)
An international litigation strategy requires coordination. For each claim, the relief sought must be assessed against the ongoing inquiry and the measures in place. This requires a clear distinction between challenging a decision and conduct that frustrates its implementation. The Enterprise Chamber also stressed that, with a Dutch sole shareholder, it would have intervened in the same way, on the strength of the conflict-of-interest conduct or the revocation of the payment powers alone. The governance problems therefore also deserve attention independently of the international conflict. (Enterprise Chamber 11 November 2026, paras 4.2 and 4.4-4.10.)
Parties wishing to bring their own proceedings as well must identify the evidence needed for each claim. The Enterprise Chamber investigation serves a different purpose from a witness examination for an individual claim. The Dutch legal interest, the overlap with foreign proceedings and the desired timing must be explained. That choice is connected with the question of which procedural route for inspection of documents is available for the evidence sought.
In a cross-border group conflict, each court measure must finally be read on its own terms: against whom is it directed, in which territory does it apply, what conduct does it prohibit, and which rights remain available? Those limits must also remain clear in the litigation strategy and day-to-day operations. For the broader background to the powers and stages involved, see the overview of inquiry proceedings before the Enterprise Chamber.
Frequently asked questions
Does ordering an inquiry already establish mismanagement?
An inquiry begins with well-founded reasons to doubt the propriety of the policy or conduct of affairs. A finding of mismanagement can follow only after the investigation, at the request of a party entitled to seek it. That distinction follows from Section 2:355 DCC.
Who pays for the Nexperia investigation?
The Enterprise Chamber has directed Nexperia Holding to bear the investigation costs and has set a budget. Who must pay those costs initially is a different question from any liability for causing the problems. The costs decision does not, in itself, establish a director's or shareholder's personal liability.
Can the Enterprise Chamber impose obligations on a foreign shareholder?
The inquiry regime does not apply to a foreign shareholder as such. However, a shareholder of a Dutch company must comply with the Enterprise Chamber's measures under Section 2:8 DCC. According to the Enterprise Chamber, the same applies to an indirect shareholder that is organisationally connected with the company and takes an active stance. The Enterprise Chamber can therefore also direct immediate measures at it. On 11 November 2026, for example, it prohibited Wingtech and Yuching from undermining the inquiry, and attached penalty payments to several specific orders. Whether such a decision is recognised abroad is a separate question.
Can anyone inspect the investigation report?
That depends on the decision about access to the report. Section 2:353 DCC distinguishes access for certain interested parties from general public access. The Enterprise Chamber may direct that the report also be available for inspection by others. Filing it with the court registry therefore does not automatically mean that the full report will be freely available online.
Cited case law
Opinions:
- Advocate General 12 June 2026, ECLI:NL:PHR:2026:584: Yuching's appeal in cassation against the urgent orders; advice to dismiss, with inadmissibility also recommended for certain decisions lifting the non-disclosure order, section 4.12 and conclusion.
- Advocate General 12 June 2026, ECLI:NL:PHR:2026:585: the director's appeal in cassation; separate appeal against the subsequent inquiry decisions mentioned in section 3.24.
Courts of appeal:
- Enterprise Chamber 1 October 2025, ECLI:NL:GHAMS:2025:2738: ex parte suspension and administration of shares, operative part.
- Enterprise Chamber 7 October 2025, ECLI:NL:GHAMS:2025:2739: administration of all but one of the shares and appointment of a director, para. 3.6 and operative part.
- Enterprise Chamber 8 October 2025, ECLI:NL:GHAMS:2025:2740: non-disclosure order partly lifted for diplomatic discussions, operative part.
- Enterprise Chamber 13 October 2025, ECLI:NL:GHAMS:2025:2742: non-disclosure order lifted in full, paras 1.3-1.6 and 2.1.
- Enterprise Chamber 13 October 2025, ECLI:NL:GHAMS:2025:2752: jurisdiction, independent submission of an inquiry petition and governance problems, paras 3.1-3.8 and 3.18-3.21.
- Enterprise Chamber 11 February 2026, ECLI:NL:GHAMS:2026:318: specific WSS orders, governance and lines of investigation, paras 3.10-3.19 and 3.30-3.35.
- Enterprise Chamber 17 February 2026, ECLI:NL:GHAMS:2026:508: appointment of the investigators, operative part.
- Enterprise Chamber 28 April 2026, ECLI:NL:GHAMS:2026:1129: investigation budget set, operative part.
- Enterprise Chamber 11 November 2026, ECLI:NL:GHAMS:2026:3160: further measures against Wingtech, Yuching and Nexperia China; Section 2:8 DCC, abuse of rights, anti-anti-suit injunction and market sounding, paras 2.19-2.50, 4.2-4.19 and operative part.
District courts:
- Gelderland District Court 2 September 2026, ECLI:NL:RBGEL:2026:6842: witness examination on the Yuching Loan permitted after filing of the investigation report; Dutch legal interest and overlapping proceedings, paras 5.14-5.28 and operative part.
- The Hague District Court 2 November 2026, corrected 5 November 2026, ECLI:NL:RBDHA:2026:32607: EU-wide counter-order protecting access to the IP courts; trade mark infringement injunctions refused, paras 5.9-5.34 and operative part, para. 6.1.